Enanta Pharmaceuticals (ENTA) Revenue Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) Revenue Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 81.24% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | -1.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21% |
| Dec 31, 2025 | -7.59% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | -2.03% |
| Mar 31, 2025 | -7.27% |
| Dec 31, 2024 | -15.03% |
| Sep 30, 2024 | -14.75% |
| Jun 30, 2024 | -5.98% |
| Mar 31, 2024 | -5.38% |
| Dec 31, 2023 | -17.23% |
| Sep 30, 2023 | -7.12% |
| Jun 30, 2023 | 0.43% |
| Mar 31, 2023 | -13.63% |
| Dec 31, 2022 | -23.45% |
| Sep 30, 2022 | -26.57% |
| Jun 30, 2022 | -24.00% |
| Mar 31, 2022 | -22.13% |
| Dec 31, 2021 | -26.59% |
| Sep 30, 2021 | -29.47% |
| Jun 30, 2021 | -27.72% |